| 000 | 00735nam a2200217Ia 4500 | ||
|---|---|---|---|
| 005 | 20260808125508.0 | ||
| 008 | 260808s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a(0195-7996) | ||
| 035 | _a6327 | ||
| 041 | _aENG | ||
| 082 | _a615.11 | ||
| 100 | _aUnited States Pharmacopeal Convention Incorporation | ||
| 245 | 0 |
_aUSP xxii NF xvii supplement no - 1 _bsupplement 1(the national formulary) |
|
| 250 | _a17th | ||
| 260 |
_aRockville _bUnited State Pharmacopeial Convention Incorporation _c1989 |
||
| 300 | _a2069 - 2206 | ||
| 500 | _a3360 / 93 - 94 / 09.07.1993 | ||
| 505 | _aUSP, United States Pharmacopoeia, drug standards, pharmaceutical reference | ||
| 650 |
_aReferences (USP) _bPharmacology -- Therapeutics |
||
| 942 | _cBK | ||
| 999 |
_c6325 _d6325 |
||